Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    The Janus Corner

    Increased Consumption of Tea and Coffee Decreases the Risk of Dying in People with Type 2 Diabetes

    wadmin1By wadmin1August 1, 2021Updated:August 5, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    I.E.Cock1,2,*
    1School of Environment and Science, Nathan Campus, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland, AUSTRALIA.
    2Environmental Futures Research Institute, Griffith University, 170 Kessels Rd, Nathan, Brisbane, Queensland, AUSTRALIA.

    Pharmacognosy Communications,2021,11,3,172-173.
    DOI:10.5530/pc.2021.3.33
    Published: August 2021
    Type: The Janus Corner

    ABSTRACT

    A recent study has reported that the consumption of relatively high levels of tea and coffee reduces all-cause mortality in individuals with type 2 diabetes mellitus (DM).1 The study monitored the health of nearly 5000 Japanese people with type 2 DM for approximately 5 years as part of a larger study to examine the effects of multiple lifestyle factors on DM. The study found that people that consumed tea and/or coffee had significantly reduced death rates (from any cause) than those that did not drink either beverage. The reduction in mortality correlated with increased consumption, with reductions of 15%, 27% and 40% for people that drank 1, 2-3, or ≥4 cups of tea daily. Similarly, 12%, 19% and 41% reductions were associated similar amounts of coffee daily. Interestingly, the two beverages seemed to potentiate each other’s protective properties. Indeed, substantially lower rates of death were reported in people that drank 2-3 cups of green tea plus 2 or more of coffee (51% decreased mortality); 4 or more cups of green tea plus 1 cup of coffee every day (58% decreased mortality); or 4 or more cups of green tea and 2 or more cups of coffee (63% decreased mortality) every day. The reasons for the protective effects of tea and coffee were not determined by that study, although both beverages are rich in phenolic antioxidants, including theonine and caffeine and these may contribute to the protective effects in DM patients.Read more…

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up